Keywords Search
Advanced search
Already a client? Login Sign up today
Language Danish English Finnish German Norwegian Portuguese Swedish Choose
Make your news visible to the world
- the right target group through the right channels at the right time.
17 Feb, 2010 08:00 CET
Orexo
Orexo AB (publ.) – Year-end Report January-December 2009
orexo , abstral , rapinyl , cancer , Japan , gerd , ox17 , pharmakodex , drug delivery , prostrakan , france , spain , edluar , meda , kyowa hakko kirin , Novartis , license , milestone payments , sales milestones , distribution agreement , pharmaceutical company
4 Feb, 2010 12:00 CET
Orexo confirms Canadian Regulatory Filing of Abstral
orexo , abstral , rapinyl , cancer , drug delivery , prostrakan , pharmeceutical company , Paladin
2 Feb, 2010 08:00 CET
Orexo announces that partner Kyowa Hakko Kirin entered a Joint Distribution Agreement on KW-2246 for treatment of cancer pain in Japan
orexo , abstral , rapinyl , cancer , Japan , drug delivery , kyowa hakko kirin , pharmeceutical company , distribution agreement
7 Jan, 2010 12:40 CET
Orexo announces that partner ProStrakan has presented strong sales figures for Abstral in Europe
orexo , abstral
10 Nov, 2009 08:00 CET
Orexo AB (publ) – Interim report January-September 2009
orexo , abstral , rapinyl , cancer , ox17 , drug delivery , france , edluar , Novartis , milestone payments , pharmeceutical company
- the right target group through the right channels at the right time.